Clinical trials
Terminated Alzheimer Disease trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2020 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Biogen | 2 |
| Hoffmann-La Roche | 2 |
| Novartis Pharmaceuticals | 2 |
| Boston Scientific Corporation | 1 |
| Myrexis Inc. | 1 |
| Palleos Healthcare GmbH | 1 |
| University of Bern | 1 |
| University of Edinburgh | 1 |
| University of Zurich | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 16 |
| Cognitive Dysfunction | 2 |
| Dementia | 2 |
| Breast Neoplasms | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.